← Back to Search

Neural Interface

Auditory Implant Evaluation for Hearing Loss

N/A

Recruiting

Led By Mahan Azadpour

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Hearing impaired adult and or child (above 2 years old) who uses ABIs or cochlear implants.

No diagnosis of any other communicative or cognitive disorder other than hearing impairment. The individual must be able to visit the lab in order to participate in behavioral and electrophysiological experiments.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1 (visit 1 - average visit length is about 3 hours)

Awards & highlights

Study Summary

This trial will study the hearing of adults and kids with hearing impairments who use implants to hear. It will evaluate how well the implants work.

Who is the study for?

This trial is for hearing-impaired adults and children over 2 years old who use cochlear or auditory brainstem implants. Participants must not have other cognitive or communicative disorders, severe neurological issues, and their implant's electrodes must be functional without causing discomfort.Check my eligibility

What is being tested?

The study investigates how well people with cochlear or auditory brainstem implants process sounds. It involves behavioral and electrophysiological experiments conducted in a lab setting to evaluate the effectiveness of these devices in restoring hearing functions.See study design

What are the potential side effects?

Since this is an observational study focusing on auditory processing, there are no direct side effects from interventions like drugs or surgeries. However, participants may experience fatigue or discomfort during testing procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am hearing impaired and use an ABI or cochlear implant.

Select...

I have no cognitive disorders except for hearing impairment and can visit the lab.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1 (visit 1 - average visit length is about 3 hours)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1 (visit 1 - average visit length is about 3 hours)

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (visit 1 - average visit length is about 3 hours) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of Correctly-Identified Speech Materials

Percent of Correctly-Identified Stimuli Characteristics when Two or More Stimuli are Presented

Trial Design

1Treatment groups

Experimental Treatment

Group I: Hearing-Impaired Individuals who use Cochlear Implants or Auditory Brainstem Implant (ABI) DevicesExperimental Treatment1 Intervention

Two types of measurements will be obtained: Perceptual: one or more sounds are presented and a behavioral response is collected (e.g., judgements of loudness, pitch or other differences between the sounds, or identifying the word or sentence that was said). Physiological: noninvasive electrophysiological recordings of nervous system activity.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Cochlear AmericasUNKNOWN

NYU Langone HealthLead Sponsor

1,369 Previous Clinical Trials

840,398 Total Patients Enrolled

16 Trials studying Hearing Loss

2,410 Patients Enrolled for Hearing Loss

Mahan AzadpourPrincipal InvestigatorNYU Langone Health

Media Library

Electrode-Neural Interface (Neural Interface) Clinical Trial Eligibility Overview. Trial Name: NCT05810220 — N/A

Hearing Loss Research Study Groups: Hearing-Impaired Individuals who use Cochlear Implants or Auditory Brainstem Implant (ABI) Devices

Hearing Loss Clinical Trial 2023: Electrode-Neural Interface Highlights & Side Effects. Trial Name: NCT05810220 — N/A

Electrode-Neural Interface (Neural Interface) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05810220 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment permit the participation of individuals aged 30 and older?

"This clinical study is seeking participants that have surpassed the age of 2 and are not yet 90 years old."

Answered by AI

Has recruitment for this experiment commenced?

"Affirmative, the information accessible on clinicaltrials.gov demonstrates that this medical trial is presently seeking volunteers. The study was first posted on December 2nd 2018 and last updated April 13th 2023, with a goal of recruiting 200 patients from one centre."

Answered by AI

How many individuals are actively participating in this clinical trial?

"Affirmative. Clinicaltrials.gov has information that shows this clinical trial is currently recruiting participants; it was initially posted on December 2nd 2018 and the listing was last updated on April 13th 2023. The investigators are looking for 200 individuals to take part, at a single site."

Answered by AI

Am I eligible to be enrolled in this clinical research?

"Eligibility for this study requires the applicant to have a hearing impairment, and be between two years old and nonagenarian. This clinical trial is seeking around 200 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

2018. "Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05810220.

All > Hearing Loss